nach oben

Erschienen in:

01.01.2023 | Research

Conversion ratios for opioid switching: a pragmatic study

verfasst von: Sebastiano Mercadante, Claudio Adile, Patrizia Ferrera, Yasmine Grassi, Alessio Lo Cascio, Alessandra Casuccio

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

The final conversion ratios among opioids used for successful switching are unknown. The aim of this study was to determine the initial and final conversion ratios used for a successful opioid switching in cancer patients, and eventual associated factors.

Methods

Ninety-five patients who were successfully switched were evaluated. The following data were collected: age, gender, Karnofsky performance score, primary cancer, cognitive function, the presence of neuropathic, and incident pain. Opioids, route of administration, and their doses expressed in oral morphine equivalents used before OS were recorded as well as opioids use for starting opioid switching, and at time of stabilization. Physical and psychological symptoms were routinely evaluated by Edmonton Symptom Assessment Scale.

Results

No statistical changes were observed between the initial conversion ratios and those achieved at time of stabilization for all the sequences of opioid switching. When considering patients switched to methadone, there was no association between factors taken into considerations.

Conclusion

Opioid switching is a highly effective and safe technique, improving analgesia and reducing the opioid-related symptom burden. The final conversion ratios were not different from those used for starting opioid switching. Patients receiving higher doses of opioids should be carefully monitored for individual and unexpected responses in an experienced palliative care unit, particularly those switched to methadone. Future studies should provide data regarding the profile of patients with difficult pain to be hospitalized.

van den Beuken-van Everdingen MH et al (2016) Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 51:1070–1090CrossRef

Portenoy RK, Ahmed E (2014) Principles of opioid use in cancer pain. J Clin Oncol 32:1662–1670CrossRef

Mercadante S (2019) The patient with difficult cancer pain. Cancers (Basel) 11:565CrossRef

Mercadante S (1999) Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86:1856–1866CrossRef

Mercadante S, Bruera E (2016) Opioid switching in cancer pain: from the beginning to nowadays. E Crit Rev Oncol Hematol 99:241–8CrossRef

Mercadante S, Caraceni A (2011) Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med 25:504–559CrossRef

Knotkova H, Fine PG, Portenoy RK (2009) Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 38:426–439CrossRef

McPherson ML (2020) Why equianalgesic tables are only part of the answer to equianalgesia. Ann Palliat Med 9:537–541CrossRef

Benítez-Rosario MA, Salinas-Martín A, Aguirre-Jaime A, Pérez-Méndez L, Feria M (2009) Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors. J Pain Symptom Manage 37:1061–1068CrossRef

10.

Reddy A, Sinclair C, Crawford GB et al (2022) Opioid rotation and conversion ratios used by palliative care professionals: an international survey. J Palliat Med 2022 5. https://doi.org/10.1089/jpm.2022.0266 Online ahead of print

11.

Mercadante S, Lo Cascio A, Adile C, Ferrera P, Casuccio A (2022) Maddalena Opioid Switching Score (MOSS) in patients with cancer pain. Pain 2022 2. https://doi.org/10.1097/j.pain.0000000000002669. Online ahead of print

12.

Mercadante S, Ferrera P, Villari P et al (2009) Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 37:632–641CrossRef

13.

Mercadante S (2012) Stop and go strategy for opioid switching requires flexibility. Eur J Cancer 48:944–945CrossRef

14.

Bouassirha D, Attal N, Alchaar H et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29–36CrossRef

15.

Mulvey MR, Boland EG, Bouhassira D et al (2017) Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles. Br J Anaesth 119:765–774CrossRef

16.

Mercadante S, Portenoy RK (2016) Breakthrough cancer pain: twenty-five years of study. Pain 157:2657–2663CrossRef

17.

Mercadante S, Coluzzi F (2021) Factors influencing pain expression in patients with cancer: an expert opinion. Pain Ther 10:765–775CrossRef

18.

Hui D, Bruera E (2017) The Edmonton Symptom Assessment System 25 years later: past, present, and future developments. J Pain Symptom Manage 53:630–643CrossRef

19.

Breibart W, Rosenfeld B, Roth A et al (1997) The Memorial Delrium Assessment Scale. J Pain Symptom Manage 13:128–137CrossRef

20.

Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E (2001) Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 22:672–678CrossRef

21.

Reddy A, Yennurajalingam S, Pulivarthi K et al (2013) Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids. Oncologist 18:212–20CrossRef

22.

Rennick A, Atkinson T, Cimino NM et al (2016) Variability in opioid equivalence calculations. Pain Med 17:892–898

23.

McPherson ML, Walker K, Davis M et al (2019) Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage 57:635–645CrossRef

24.

Quigley C (2004) Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev (3): CD004847

25.

Mercadante S, Casuccio A, Calderone L (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 17:3307–3312CrossRef

26.

Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13:399–404CrossRef

27.

Mercadante S, Ferrera P, Villari P, Casuccio A (2005) Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 23:5229–5234CrossRef

28.

Watanabe S, Tarumi Y, Oneschuk D, Lawlor P (2002) Opioid rotation to methadone: proceed with caution. J Clin Oncol 20:2409–2410CrossRef

29.

Mancini I, Lossignol DA, Body JJ (2000) Opioid switch to oral methadone in cancer pain. Curr Opin Oncol 12:308–313CrossRef

30.

Hagen NA, Wasylenko E (1999) Methadone: outpatient titration and monitoring strategies in cancer patients. J Pain Symptom Manage 18:369–375CrossRef

31.

Parsons HA, de la Cruz M, El Osta B et al (2010) Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer 116:520–528CrossRef

32.

Porta-Sales J, Garzón-Rodríguez C, Villavicencio-Chávez C, Llorens-Torromé S, González-Barboteo J (2016) Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist 21:981–7CrossRef

33.

Walker PW, Palla S, Pei BL et al (2008) Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med 11:1103–1108CrossRef

34.

35.

Mercadante S, Bruera E (2012) The effect of age on opioid switching to methadone: a systematic review. J Palliat Med 15:347–351CrossRef

36.

Gagnon B, Bruera E (1999) Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. J Pain Symptom Manage 18:120–125CrossRef

37.

Oian Y, Haider A, Lu Z et al (2020) Factors associated with improvement in uncontrolled cancer pain without increasing the opioid daily dose among patients seen by an inpatient palliative care team. J Palliat Med 23:483–488CrossRef

38.

Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13:399–404CrossRef

Titel: Conversion ratios for opioid switching: a pragmatic study
verfasst von: Sebastiano Mercadante
Claudio Adile
Patrizia Ferrera
Yasmine Grassi
Alessio Lo Cascio
Alessandra Casuccio
Publikationsdatum: 01.01.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-022-07514-4

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Conversion ratios for opioid switching: a pragmatic study